Taiwan
· Delayed Price · Currency is TWD Microbio Statistics
Total Valuation
Microbio has a market cap or net worth of TWD 21.06 billion. The enterprise value is 19.35 billion.
| Market Cap | 21.06B |
| Enterprise Value | 19.35B |
Important Dates
The last earnings date was Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Microbio has 588.17 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 588.17M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 7.27% |
| Float | 428.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.53 |
| PB Ratio | 1.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 44.41 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -22.14 |
| EV / Sales | 11.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 40.81 |
Financial Position
The company has a current ratio of 8.63, with a Debt / Equity ratio of 0.05.
| Current Ratio | 8.63 |
| Quick Ratio | 8.15 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.26 |
| Interest Coverage | -26.24 |
Financial Efficiency
Return on equity (ROE) is -8.15% and return on invested capital (ROIC) is -1.20%.
| Return on Equity (ROE) | -8.15% |
| Return on Assets (ROA) | -1.11% |
| Return on Capital (ROIC) | -1.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 5.45 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.31% in the last 52 weeks. The beta is 1.37, so Microbio's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -28.31% |
| 50-Day Moving Average | 39.28 |
| 200-Day Moving Average | 40.11 |
| Relative Strength Index (RSI) | 36.63 |
| Average Volume (20 Days) | 929,416 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Microbio had revenue of TWD 1.68 billion and -873.89 million in losses. Loss per share was -1.49.
| Revenue | 1.68B |
| Gross Profit | 648.19M |
| Operating Income | -259.38M |
| Pretax Income | -1.06B |
| Net Income | -873.89M |
| EBITDA | -145.55M |
| EBIT | -259.38M |
| Loss Per Share | -1.49 |
Balance Sheet
The company has 3.91 billion in cash and 597.23 million in debt, giving a net cash position of 3.31 billion or 5.63 per share.
| Cash & Cash Equivalents | 3.91B |
| Total Debt | 597.23M |
| Net Cash | 3.31B |
| Net Cash Per Share | 5.63 |
| Equity (Book Value) | 12.50B |
| Book Value Per Share | 18.38 |
| Working Capital | 3.93B |
Cash Flow
In the last 12 months, operating cash flow was 514.70 million and capital expenditures -40.60 million, giving a free cash flow of 474.10 million.
| Operating Cash Flow | 514.70M |
| Capital Expenditures | -40.60M |
| Free Cash Flow | 474.10M |
| FCF Per Share | 0.81 |
Margins
Gross margin is 38.54%, with operating and profit margins of -15.42% and -51.96%.
| Gross Margin | 38.54% |
| Operating Margin | -15.42% |
| Pretax Margin | -62.94% |
| Profit Margin | -51.96% |
| EBITDA Margin | -8.65% |
| EBIT Margin | -15.42% |
| FCF Margin | 28.19% |
Dividends & Yields
Microbio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | -4.16% |
| FCF Yield | 2.25% |
Stock Splits
The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.
| Last Split Date | Aug 29, 2024 |
| Split Type | Forward |
| Split Ratio | 1.049999998 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |